Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer

Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer

ObjectivesSpingosine-1-phosphate (S1P) and ceramides are bioactive sphingolipids that influence cancer cell fate. Anti-ceramide antibodies might inhibit the effects of ceramide. The aim of this study was to assess the potential role of circulating S1P and anti-ceramide antibody as biomarkers in non-...

Full description

Saved in:

Bibliographic Details
Main Authors:	Lilla Bűdi, Dániel Hammer, Rita Varga, Veronika Müller, Ádám Domonkos Tárnoki, Dávid László Tárnoki, Martina Mészáros, András Bikov, Péter Horváth
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Pathology and Oncology Research
Subjects:	S1P anti-ceramide antibody NSCLC biomarkers lung cancer
Online Access:	https://www.por-journal.com/articles/10.3389/pore.2024.1611929/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Glycosylation of ceramide synthase 6 is required for its activity
by: Alexandra J. Straus, et al.
Published: (2025-01-01)

Lysosphingolipids in ceramide-deficient skin lipid models
by: Georgios Paraskevopoulos, et al.
Published: (2025-01-01)

Role of dietary and nutritional interventions in ceramide-associated diseases
by: Shengnan Wang, et al.
Published: (2025-01-01)

Optical control of sphingolipid biosynthesis using photoswitchable sphingosines
by: Matthijs Kol, et al.
Published: (2025-01-01)

Integrating the GRACE Score with the Ceramide Risk Score Enhances the Predictive Accuracy of Major Adverse Cardiac Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
by: Xiaofei Wang, et al.
Published: (2024-12-01)

The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
by: Lin Wang, et al.
Published: (2025-02-01)

Analysis of fatty acid-derived lipids in critically ill patients after cardiac surgery yields novel pathophysiologically relevant mediators with possible relevance for systemic inflammatory reactions
by: Holger Neb, et al.
Published: (2025-01-01)

Concurrent versus sequential immunotherapy with chemoradiotherapy for unresectable stage III non-small-cell lung cancer: a retrospective study
by: Zhou Meng-Xi, et al.
Published: (2025-01-01)

Circulating Clusterin and Osteopontin Levels in Asthma and Asthmatic Pregnancy
by: Brigitta Dombai, et al.
Published: (2017-01-01)

Reduction in serum sphingosine 1-phosphate concentration in malaria.
by: Chuchard Punsawad, et al.
Published: (2017-01-01)

Clinical Impact of Sphingosine-1-Phosphate in Breast Cancer
by: Junko Tsuchida, et al.
Published: (2017-01-01)

Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
by: Huanyu Z. Li, et al.
Published: (2025-01-01)

Signal Transduction of Sphingosine-1-Phosphate G Protein—Coupled Receptors
by: Nicholas Young, et al.
Published: (2006-01-01)

Differential Expression of Sphingosine-1-Phosphate Receptors in Abdominal Aortic Aneurysms
by: Z. Qu, et al.
Published: (2012-01-01)

Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
by: Masayo Aoki, et al.
Published: (2016-01-01)

The palmitoyl-CoA ligase Fum16 is part of a Fusarium verticillioides fumonisin subcluster involved in self-protection
by: Fabio Gherlone, et al.
Published: (2025-02-01)

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Comparative efficacy of repurposed drugs lopinavir-ritonavir and darunavir-ritonavir in hospitalised COVID-19 patients: insights from a tertiary centre cohort
by: Dóra Paróczai, et al.
Published: (2025-01-01)

Corrigendum to “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential”
by: Masayo Aoki, et al.
Published: (2016-01-01)

Paradoxical Association of Postoperative Plasma Sphingosine-1-Phosphate with Breast Cancer Aggressiveness and Chemotherapy
by: Rajesh Ramanathan, et al.
Published: (2017-01-01)

PET Study of Sphingosine-1-phosphate Receptor 1 Expression in Response to S. aureus Infection
by: Hao Jiang, et al.
Published: (2021-01-01)

Sphingosine-1-Phosphate/Sphingosine-1-Phosphate Receptor 2 Axis Can Promote Mouse and Human Primary Mast Cell Angiogenic Potential through Upregulation of Vascular Endothelial Growth Factor-A and Matrix Metalloproteinase-2
by: Alena Chumanevich, et al.
Published: (2016-01-01)

CTSG is a prognostic marker involved in immune infiltration and inhibits tumor progression though the MAPK signaling pathway in non-small cell lung cancer
by: Qian Dai, et al.
Published: (2024-12-01)

Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway
by: Wang Naizhi, et al.
Published: (2020-09-01)

Targeting HVEM-GPT2 axis: a novel approach to T cell activation and metabolic reprogramming in non-small cell lung cancer therapy
by: Yuanshan Yao, et al.
Published: (2025-02-01)

Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes
by: Sivakamavalli Jeyachandran
Published: (2024-06-01)

Sex-dependent efficacy of sphingosine-1-phosphate receptor agonist FTY720 in mitigating Huntington’s disease
by: Jingyun Wu, et al.
Published: (2025-01-01)

AMPK: An energy sensor for non-small cell lung cancer progression and treatment
by: Zhi-Ting Zhong, et al.
Published: (2025-02-01)

Circulating Tumor DNA Detection for Recurrence Monitoring of Stage I Non‐Small Cell Lung Cancer Treated With Microwave Ablation
by: Lin Cheng, et al.
Published: (2025-01-01)

Safety of brigatinib following alectinib-induced-pneumonitis: Case report
by: Blerina Resuli, et al.
Published: (2025-01-01)

Trends in the Use of Sphingosine 1 Phosphate in Age-Related Diseases: A Scientometric Research Study (1992-2020)
by: Qiong He, et al.
Published: (2021-01-01)

Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH
by: Gopanandan Parthasarathy, et al.
Published: (2025-02-01)

Sphingolipid and Ceramide Homeostasis: Potential Therapeutic Targets
by: Simon A. Young, et al.
Published: (2012-01-01)

The compensatory enrichment of sphingosine-1-phosphate on HDL in FSGS enhances the protective function of glomerular endothelial cells compared to MCD
by: Yunfeng Xiong, et al.
Published: (2025-01-01)

Husserl „utolsó könyve” – Filozófiatörténet és véglegesség-igény Husserl késői filozófiájában
by: Péter András Varga
Published: (2012-04-01)

LRP1 involvement in FHIT-regulated HER2 signaling in non-small cell lung cancer
by: Théophile Ponchel, et al.
Published: (2025-03-01)

Unveiling the immunomodulatory dance: endothelial cells’ function and their role in non-small cell lung cancer
by: Sophia Daum, et al.
Published: (2025-01-01)

Metabolically activated and highly polyfunctional intratumoral VISTA+ regulatory B cells are associated with tumor recurrence in early-stage NSCLC
by: Domenico Lo Tartaro, et al.
Published: (2025-01-01)

Sotorasib resistance triggers epithelial-mesenchymal transition and activates AKT and P38-mediated signaling
by: Raquel Arantes Megid, et al.
Published: (2025-01-01)

Impact of EML4‐ALK Variants and TP53 Status on the Efficacy of ALK Inhibitors in Patients With Non‐small Cell Lung Cancer
by: Zihua Zou, et al.
Published: (2025-01-01)